These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 9373264)
1. Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Mrózek K; Heinonen K; Lawrence D; Carroll AJ; Koduru PR; Rao KW; Strout MP; Hutchison RE; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD Blood; 1997 Dec; 90(11):4532-8. PubMed ID: 9373264 [TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry. Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125 [TBL] [Abstract][Full Text] [Related]
3. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312 [TBL] [Abstract][Full Text] [Related]
4. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint. Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements]. He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048 [TBL] [Abstract][Full Text] [Related]
6. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569 [TBL] [Abstract][Full Text] [Related]
7. Granulocytic sarcomas in body cavities in childhood acute myeloid leukemias with 11q23/MLL rearrangements. Johansson B; Fioretos T; Kullendorff CM; Wiebe T; Békássy AN; Garwicz S; Forestier E; Roos G; Akerman M; Mitelman F; Billström R Genes Chromosomes Cancer; 2000 Feb; 27(2):136-42. PubMed ID: 10612801 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival. Martinez-Climent JA; Espinosa R; Thirman MJ; Le Beau MM; Rowley JD J Pediatr Hematol Oncol; 1995 Nov; 17(4):277-83. PubMed ID: 7583381 [TBL] [Abstract][Full Text] [Related]
9. Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Kawasaki H; Isoyama K; Eguchi M; Hibi S; Kinukawa N; Kosaka Y; Oda T; Oda M; Nishimura S; Imaizumi M; Okamura T; Hongo T; Okawa H; Mizutani S; Hayashi Y; Tsukimoto I; Kamada N; Ishii E Blood; 2001 Dec; 98(13):3589-94. PubMed ID: 11739161 [TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J; Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663 [TBL] [Abstract][Full Text] [Related]
11. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Drexler HG; Quentmeier H; MacLeod RA Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638 [TBL] [Abstract][Full Text] [Related]
12. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152 [TBL] [Abstract][Full Text] [Related]
13. Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. Giugliano E; Rege-Cambrin G; Scaravaglio P; Wlodarska I; Emanuel B; Stul M; Serra A; Tonso A; Pini M; Saglio G; Hagemeijer A Haematologica; 2002 Oct; 87(10):1014-20. PubMed ID: 12368154 [TBL] [Abstract][Full Text] [Related]
14. MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia. Hilden JM; Smith FO; Frestedt JL; McGlennen R; Howells WB; Sorensen PH; Arthur DC; Woods WG; Buckley J; Bernstein ID; Kersey JH Blood; 1997 May; 89(10):3801-5. PubMed ID: 9160687 [TBL] [Abstract][Full Text] [Related]
15. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia. Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106 [TBL] [Abstract][Full Text] [Related]
16. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Balgobind BV; Raimondi SC; Harbott J; Zimmermann M; Alonzo TA; Auvrignon A; Beverloo HB; Chang M; Creutzig U; Dworzak MN; Forestier E; Gibson B; Hasle H; Harrison CJ; Heerema NA; Kaspers GJ; Leszl A; Litvinko N; Nigro LL; Morimoto A; Perot C; Pieters R; Reinhardt D; Rubnitz JE; Smith FO; Stary J; Stasevich I; Strehl S; Taga T; Tomizawa D; Webb D; Zemanova Z; Zwaan CM; van den Heuvel-Eibrink MM Blood; 2009 Sep; 114(12):2489-96. PubMed ID: 19528532 [TBL] [Abstract][Full Text] [Related]
17. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439 [TBL] [Abstract][Full Text] [Related]
18. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23. Smith FO; Rauch C; Williams DE; March CJ; Arthur D; Hilden J; Lampkin BC; Buckley JD; Buckley CV; Woods WG; Dinndorf PA; Sorensen P; Kersey J; Hammond D; Bernstein ID Blood; 1996 Feb; 87(3):1123-33. PubMed ID: 8562938 [TBL] [Abstract][Full Text] [Related]
19. Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis. Martinez-Climent JA; Thirman MJ; Espinosa R; Le Beau MM; Rowley JD Leukemia; 1995 Aug; 9(8):1299-304. PubMed ID: 7643616 [TBL] [Abstract][Full Text] [Related]
20. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies. Zhang Y; Poetsch M; Weber-Matthiesen K; Rohde K; Winkemann M; Haferlach T; Gassmann W; Ludwig WD; Grote W; Löffler H; Schlegelberger B Br J Haematol; 1996 Mar; 92(3):673-80. PubMed ID: 8616034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]